INTERSTITIAL GRANULOMATOUS DERMATITIS

This adverse event was reported 193 times

These drugs are most commonly taken by patients reporting INTERSTITIAL GRANULOMATOUS DERMATITIS:

# Drug Count
0 HYDROCHLOROTHIAZIDE 23
1 AMLODIPINE 20
2 ADALIMUMAB 15
3 CITALOPRAM 14
4 CITALOPRAM HYDROBROMIDE 14
5 GABAPENTIN 14
6 INFLIXIMAB 14
7 METHOTREXATE SODIUM 11
8 RABEPRAZOLE 11
9 SIMVASTATIN 11
See all common drugs associated with INTERSTITIAL GRANULOMATOUS DERMATITIS

INTERSTITIAL GRANULOMATOUS DERMATITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 6 0.0087
1 CD38-directed Cytolytic Antibody [EPC] 2 0.0003
2 Vitamin D3 Analog [EPC] 6 0.0003
3 Provitamin D2 Compound [EPC] 8 0.0003
4 Antimalarial [EPC] 2 0.0002
5 Antiprotozoal [EPC] 2 0.0002
6 Thiazide Diuretic [EPC] 24 0.0001
7 CD52-directed Cytolytic Antibody [EPC] 2 0.0001
8 Serotonin Reuptake Inhibitor [EPC] 9 0.0001
9 Thiazide-like Diuretic [EPC] 4 0.0001
See all drug classes enriched for association with INTERSTITIAL GRANULOMATOUS DERMATITIS